The Executive Director of RESULTS Aaron Oxley has had a letter published in the Guardian, calling on GlaxoSmithKline and other members of the pharmaceutical industry to combat TB.
“Andrew Witty and GSK should be commended for unilaterally sharing drug research that may help find a cure for malaria (Glaxo offers free access to potential malaria cures, 20 January). It is a bold move that has created a “patent pool” for real global public good. However, tuberculosis, which kills 5,000 people a day – more than malaria and a similar number to HIV/Aids – receives nowhere near the attention from the pharmaceutical industry that either of these diseases receive. TB is a neglected disease with an enormous human cost, and we look forward to the day when GSK and others announce a similar effort to combat it.”